semaglutide after 3 months Before and After: Real Results GLP-1 Weight Loss Results |
Description
References Nference & Mayo Clinic (2025)
The FDA labels for GLP-1 medications list a higher chance of gallstones and gallbladder disease as a potential risk
FDA's investigation is ongoing, and the agency is working to protect the U.S
The confusion that ensues is borne by the consumer
